News 2023-06-23
Dr. Angelo Maria Manzo of Porton Pharma Solutions Joins BOS Basel 2023, Spearheading Collaborations and Growth Opportunities
Dr. Angelo Maria Manzo, our esteemed Senior Business Development Manager at Porton Pharma Solutions Ltd., joins us at BOS Basel 2023!
Angelo’s deep industry knowledge and strategic vision are set to make a remarkable impact as he explores new collaborations, identifies growth opportunities, and expands our network.
Drop by Stand 17 to catch up with him during the 2-day event in Basel, Switzerland!
If you would like to preschedule a meeting, https://lnkd.in/eFzuWJBN
Others
More
News 2026-08-05
Porton Advanced Secures Drug Manufacturing License (Class C), Expanding CDMO Services to Commercialization
Porton Advanced Solutions Ltd. has officially been granted a Drug Manufacturing License (Class C) by the National Medical Products Administration (NMPA). This milestone qualifies Porton Advanced to undertake commercial contract manufacturing for Cell and Gene Therapy (CGT) products, extending its CDMO services from process development and clinical production through to the commercialization stage.
News 2026-07-08
Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
Porton Advanced’s UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
